Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
HK Stock MarketDetailed Quotes
5100 XIZANG (01115)
- 0.450
- -0.010-2.17%
Not Open May 18 16:47 CST
2.53BMarket Cap26.47P/E (TTM)
0.460High0.445Low13.25MVolume0.460Open0.460Prev Close5.98MTurnover0.24%Turnover Ratio26.47P/E (Static)5.63BShares0.76052wk High0.80P/B2.53BFloat Cap0.24052wk Low--Dividend TTM5.63BShs Float3.434Historical High--Dividend LFY3.26%Range %0.194Historical Low0.451Avg Price10000Lot Size--Div Yield TTM--Div Yield LFY
5100 XIZANG (01115) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 58.51%357.94M | 21.39%168.51M | -28.18%225.81M | -19.75%138.82M | 0.80%314.43M | -5.92%172.97M | -31.61%311.95M | -17.68%183.85M | -7.46%456.13M | 0.16%223.34M |
| Operating income | 58.51%357.94M | 21.39%168.51M | -28.18%225.81M | -19.75%138.82M | 0.80%314.43M | -5.92%172.97M | -31.61%311.95M | -17.68%183.85M | -7.46%456.13M | 0.16%223.34M |
| Cost of sales | -8.60%-178.78M | 14.54%-93.65M | 30.48%-164.63M | 10.76%-109.59M | -7.13%-236.81M | -1.21%-122.8M | 16.64%-221.06M | 9.91%-121.34M | 4.53%-265.18M | -11.07%-134.69M |
| Operating expenses | -8.60%-178.78M | 14.54%-93.65M | 30.48%-164.63M | 10.76%-109.59M | -7.13%-236.81M | -1.21%-122.8M | 16.64%-221.06M | 9.91%-121.34M | 4.53%-265.18M | -11.07%-134.69M |
| Gross profit | 192.82%179.15M | 156.11%74.86M | -21.17%61.18M | -41.74%29.23M | -14.60%77.61M | -19.74%50.17M | -52.41%90.88M | -29.48%62.51M | -11.24%190.95M | -12.85%88.65M |
| Selling expenses | 42.60%-36.17M | 24.57%-14.77M | -25.36%-63M | -16.70%-19.58M | -68.84%-50.25M | -36.95%-16.78M | 44.34%-29.77M | 57.70%-12.25M | 48.99%-53.48M | 26.47%-28.96M |
| Administrative expenses | 3.48%-74.13M | 8.80%-29.69M | 13.67%-76.81M | 13.00%-32.56M | -18.71%-88.97M | -9.40%-37.42M | -3.57%-74.95M | -10.99%-34.2M | -6.77%-72.37M | 6.93%-30.82M |
| Impairment and provision | 89.45%-5.04M | -234.64%-3.89M | -29.19%-47.73M | 127.77%2.89M | 58.31%-36.94M | -35.23%-10.4M | -63.39%-88.62M | 71.42%-7.69M | -438.72%-54.24M | -166.57%-26.89M |
| -Other impairment is provision | 89.45%-5.04M | -234.64%-3.89M | -29.19%-47.73M | 127.77%2.89M | 58.31%-36.94M | -35.23%-10.4M | -63.39%-88.62M | 71.42%-7.69M | -438.72%-54.24M | -166.57%-26.89M |
| Special items of operating profit | 24.65%35.83M | -68.05%11.83M | 89.50%28.74M | 425.90%37.04M | -17.84%15.17M | -42.71%7.04M | -30.31%18.46M | -31.88%12.29M | 18.23%26.49M | 71.31%18.05M |
| Operating profit | 202.09%99.65M | 125.28%38.35M | -17.06%-97.61M | 330.79%17.02M | 0.71%-83.39M | -135.69%-7.38M | -324.76%-83.98M | 3.20%20.66M | -53.83%37.37M | -32.49%20.02M |
| Financing income | ---- | 114.95%759K | ---- | ---5.08M | ---- | ---- | ---- | -97.85%746K | ---- | 7.72%34.73M |
| Financing cost | 18.84%-3.09M | ---- | -79.98%-3.81M | ---- | 13.16%-2.12M | --1.03M | -111.90%-2.44M | ---- | --20.5M | ---- |
| Special items of earning before tax | 99.46%-2.56M | -32.44%-2.73M | -80.19%-471.04M | 14.44%-2.06M | -2,344.44%-261.41M | 68.75%-2.41M | -133,775.00%-10.69M | -586.21%-7.71M | 100.38%8K | 29.62%-1.12M |
| Earning before tax | 116.42%93.99M | 268.07%36.37M | -65.02%-572.46M | 212.89%9.88M | -257.21%-346.91M | -163.92%-8.75M | -267.81%-97.12M | -74.46%13.7M | 66.67%57.87M | -11.07%53.62M |
| Tax | -422.22%-7.76M | 78.46%-182K | 75.06%-1.49M | 82.07%-845K | -11.31%-5.95M | 19.77%-4.71M | 51.01%-5.35M | 34.88%-5.87M | 38.67%-10.92M | 8.90%-9.02M |
| After-tax profit from continuing operations | 115.03%86.24M | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 177.54%46.95M | -11.50%44.6M |
| Earning after tax | 115.03%86.24M | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 177.54%46.95M | -11.50%44.6M |
| Profit attributable to shareholders | 115.03%86.24M | 300.48%36.19M | -62.65%-573.95M | 167.10%9.04M | -244.37%-352.87M | -272.19%-13.47M | -318.23%-102.47M | -82.47%7.82M | 176.64%46.95M | -11.50%44.6M |
| Basic earnings per share | 114.16%0.0183 | 276.19%0.0079 | -44.04%-0.1292 | 160.00%0.0021 | -143.09%-0.0897 | -216.67%-0.0035 | -300.54%-0.0369 | -83.15%0.003 | 170.59%0.0184 | -11.44%0.0178 |
| Diluted earnings per share | 113.93%0.018 | 276.19%0.0079 | -44.04%-0.1292 | 160.00%0.0021 | -143.09%-0.0897 | -216.67%-0.0035 | -300.54%-0.0369 | -82.25%0.003 | 170.59%0.0184 | -15.92%0.0169 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"